Decreased serotonin function in bulimia nervosa

Archives of General Psychiatry

Volumn 54, Issue 6, 1997, Pages 529-534

  Jimerson, David C ^a,g   Wolfe, Barbara E ^a   Metzger, Eran D ^a   Finkelstein, Dianne M ^b   Cooper, Thomas B ^c,d   Levine, Jeffrey M ^a,e,f  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^d NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^e ST MARY S HOSPITAL   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENFLURAMINE; PLACEBO; PROLACTIN; SEROTONIN;

ADULT; ANXIETY; ARTICLE; BULIMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; NEUROENDOCRINE SYSTEM; ORAL DRUG ADMINISTRATION; SEROTONINERGIC SYSTEM; SINGLE BLIND PROCEDURE; SYMPTOMATOLOGY;

EID: 0030922999     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.1997.01830180043005     Document Type: Article

References (58)

1. Kassett JA, Gershon ES, Maxwell ME, Guroff JJ, Kazuba DM, Smith AL, Brandt HA, Jimerson DC. Psychiatric disorders in the first-degree relatives of probands with bulimia nervosa. Am J Psychiatry. 1989;146:1468-1471.
2. Kendler KS, MacLean C, Neale M, Kessler R, Heath A, Eaves L. The genetic epidemiology of bulimia nervosa. Am J Psychiatry. 1991;148:1627-1637.
3. Jimerson DC, Lesem MD, Hegg AP, Brewerton TD. Serotonin in human eating disorders. Ann N Y Acad Sci. 1990;600:532-544.
4. Leibowitz SF, Weiss GF, Suh JS. Medial hypothalamic nuclei mediate serotonin's inhibitory effect on feeding behavior. Pharmacol Biochem Behav. 1990; 37:735-742.
5. Blundell JE. Serotonin and appetite. Neuropharmacology. 1984;23:1537-1551.
6. 2 receptor agonists using the post-prandial satiety sequence in rats. Psychopharmacology. 1994;113:369-377.
7. Aulakh CS, Mazzola-Pomietto P, Wozniak KM, Hill JL, Murphy DL. Evidence that 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane-induced hypophagia and hyperthermia in rats is mediated by serotonin-2A receptors. J Pharmacol Exp Ther. 1994;270:127-132.
8. Brewerton TD, Murphy DL, Jimerson DC. Testmeal responses following m-chlorophenylpiperazine and L-tryptophan in bulimics and controls. Neuropsychopharmacology. 1994;11:63-74.
9. Chiodo J, Latimer PR. Hunger perceptions and satiety responses among normal-weight bulimics and normals to a high-calorie, carbohydrate-rich food. Psychol Med. 1986;16:343-349.
10. LaChaussee JL, Kissileff HR, Walsh BT, Hadigan CM. The single-item meal as a measure of binge-eating behavior in patients with bulimia nervosa. Physiol Behav. 1992;51:593-600.
11. Chaput Y, Demontigny C, Blier P. Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments: an in vivo electrophysiologic study in the rat. Neuropsychopharmacology. 1991;5:219-229.
12. Fluoxetine Bulimia Nervosa Collaborative Study Group. Fluoxetine in the treatment of bulimia nervosa: a multicenter, placebo-controlled, double-blind trial. Arch Gen Psychiatry. 1992;49:139-147.
13. Jimerson OC, Herzog DB, Brotman AW. Pharmacological approaches in the treatment of eating disorders. Harvard Rev Psychiatry. 1993;1:82-93.
14. Brewerton TD, Mueller EA, Lesem MD, Brandt HA, Quearry B, George DT, Murphy DL, Jimerson DC. Neuroendocrine responses to m-chlorophenylpiperazine and L-tryptophan in bulimia. Arch Gen Psychiatry. 1992;49:852-861.
15. Price LH, Charney DS, Delgado PL, Heninger GR. Serotonin function and depression: neuroendocrine and mood responses to intravenous L-tryptophan in depressed patients and healthy comparison subjects. Am J Psychiatry. 1991; 148:1518-1525.
16. O'Keane V, O'Hanlon M, Webb M, Dinan T. d-fenfluramine prolactin response throughout the menstrual cycle: evidence for an oestrogen-induced alteration. Clin Endocrinol (Oxf). 1991;34:289-292.
17. Dannies PS. Control of prolactin production by estrogen. In: Litwack G, ed. Biochemical Actions of Hormones. Orlando, Fla: Academic Press Inc; 1985: 289-307.
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington DC: American Psychiatric Press; 1987.
19. Endicott J, Spitzer RL. A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry. 1978;35:837-844.
20. Society of Actuaries, Association of Life Insurance Medical Directors of America. Build Study, 1979. Chicago, Ill: Society of Actuaries; 1980.
21. Gilmore JH, Ruegg RG, Ekstrom RD, Knight B, Carson SW, Mason GA, Golden RN. Altered prolactin response to clomipramine rechallenge in healthy subjects. Biol Psychiatry. 1993;34:885-888.
22. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
23. Garner DM, Olmsted MP, Bohr Y, Garfinkel PE. The Eating Attitudes Test: psychometric features and clinical correlates. Psychol Med. 1982;12:871-878.
24. Spielberger CD. Manual for the State-Trait Anxiety Inventory (STAI-Form-Y). Palo Alto, Calif: Consulting Psychologist Press; 1983.
25. Krebs HA, Cheng LK, Wright GJ. Determination of fenfluramine and norfenfluramine in plasma using a nitrogen-sensitive detector. J Chromatogr. 1984; 310:412-417.
26. Denckla WD, Dewey HK. The determination of tryptophan in plasma, liver, and urine. J Lab Clin Med. 1967;69:160-169.
27. Salzman C, Jimerson D, Vasile R, Watsky E, Gerber J. Response to SSRI antidepressants correlates with reduction in plasma HVA: pilot study. Biol Psychiatry. 1993;34:569-571.
28. Norusis MJ. SPSS for Windows: Base System User's Guide, Release 6.0. Chicago, Ill: SPSS Inc; 1993.
29. Jimerson DC, Lesem MD, Kaye WH, Brewerton TD. Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes. Arch Gen Psychiatry. 1992;49:132-138.
30. Goldbloom D, Garfinkel P, Katz R, Brown G. The hormonal response to intravenous 5-hydroxytryptophan in bulimia nervosa. Psychosom Med. 1990;52: 225-226. Abstract.
31. McBride PA, Anderson GM, Khait VD, Sunday SR, Halmi KA. Serotonergic responsivity in eating disorders. Psychopharmacol Bull. 1991;27:365-372.
32. Levitan RD, Kaplan AS, Levitt AJ, Joffe RT. Hormonal and subjective responses to intravenous m-chtorophenylpiperazine (m-CPP) in bulimia nervosa and normal controls. Proc Int Conference Eating Disord. 1994;6:104. Abstract.
33. Siever LJ, Murphy DL, Slater S, de la Vega E, Lipper S. Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression. Life Sci. 1984;34: 1029-1039.
34. O'Keane V, Dinan TG. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. Am J Psychiatry. 1991;148:1009-1015.
35. Coccaro EF, Siever LJ, Owen K, Davis KL. Serotonin in mood and personality disorders. In: Coccaro EF, Murphy DL, eds. Serotonin In Major Psychiatric Disorders. Washington DC: American Psychiatric Press; 1990:69-97.
36. McBride PA, Anderson GM, Hertzig ME, Sweeney JA, Kream J, Cohen DJ, Mann JJ. Serotonergic responsivity in male young adults with autistic disorder: results of a pilot study. Arch Gen Psychiatry. 1989;46:213-221.
37. Miller HL, Delgado PL, Salomon RM, Berman R, Krystal JH, Heninger GR, Charney DS. Clinical and biochemical effects of catecholamine depletion on anti-depressant-induced remission of depression. Arch Gen Psychiatry. 1996;53: 117-128.
38. Wolfe BE, Jimerson DC, Metzger ED, Levine JM. Serotonergic challenge responses in women with a history of bulimia nervosa. Biol Psychiatry. 1994; 35:736-737. Abstract.
39. Delgado PL, Charney DS, Price LH, Landis H, Heninger GR. Neuroendocrine and behavioral effects of dietary tryptophan restriction in healthy subjects. Life Sci. 1989;45:2323-2332.
40. Anderson IM, Parry-Billings M, Newsholme EA, Fairburn CG, Cowen PJ. Dieting reduces plasma tryptophan and alters brain 5-HT function in women. Psychol Med. 1990;20:785-791.
41. Walsh AES, Oldman AD, Franklin M, Fairburn CG, Cowen PJ. Dieting decreases plasma tryptophan and increases the prolactin response to d-fenfluramine in women but not men. J Affect Disord. 1995;33:89-97.
42. 2 and thyroid hormones in healthy subjects. Am J Clin Nutr. 1982;35:24-35.
43. Pirke KM, Pahl J, Schweiger U, Warnhoff M. Metabolic and endocrine indices of starvation in bulimia: a comparison with anorexia nervosa. Psychiatry Res. 1985;15:33-39.
44. Obarzanek E, Lesem MD, Goldstein DS, Jimerson DC. Reduced resting metabolic rate in patients with bulimia nervosa. Arch Gen Psychiatry. 1991;48:456-462.
45. Levy AB, Dixon KN, Malarkey WB. Pituitary response to TRH in bulimia. Biol Psychiatry. 1988;23:476-484.
46. Weltzin TE, McConaha C, McKee M, Hsu LKG, Perel J, Kaye WH. Circadian patterns of cortisol, prolactin, and growth hormone secretion during binging and vomiting in normal weight bulimic patients. Biol Psychiatry. 1991;30:37-48.
47. Kaplan AS, Garfinkel PE, Brown GM. The DST and TRH test in bulimia nervosa. Br J Psychiatry. 1989;154:86-92.
48. Ben-Jonathan N. Regulation of prolactin secretion. In: Imura H, ed. The Pituitary Gland. 2nd ed. New York, NY: Raven Press; 1994:261-283.
49. Garattini S, Mennini T, Bendotti C, Invernizzi R, Samanin R. Neurochemical mechanism of action of drugs which modify feeding via the serotoninergic system. Appetite. 1986;7(suppl):15-38.
50. Murphy DL. Peripheral indices of central serotonin function in humans. Ann N Y Acad Sci. 1990;600:282-295.
51. Van de Kar LD. Neuroendocrine pharmacology of serotonergic (5-HT) neurons. Annu Rev Pharmacol Toxicol. 1991;31:289-320.
52. Mann JJ, McBride PA, Brown RP, Linnoila M, Leon AC, DeMeo M, Mieczkowski T, Myers JE, Stanley M. Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients. Arch Gen Psychiatry. 1992;49:442-446.
53. Cowen PJ. Serotonin receptor subtypes in depression: evidence from studies in neuroendocrine regulation. Clin Neuropharmacol. 1993;16(suppl 3):S6-S18.
54. Invernizzi R, Bertorelli R, Consolo S, Garattini S, Samanin R. Effects of the I-isomer of fenfluramine on dopamine mechanisms in the rat brain: further studies. Eur J Pharmacol. 1989;164:241-248.
55. Coccaro EF, Kavoussi RJ, Hauger R. PRL and HVA responses to d- and d,I-fenfluramine in humans. Biol Psychiatry. 1994;35:644. Abstract.
56. Brewerton TD, Brandt HA, Lesern MD, Murphy DL, Jimerson DC. Serotonin in eating disorders. In: Coccaro EF, Murphy DL, eds. Serotonin in Major Psychiatric Disorders. Washington DC: American Psychiatric Press; 1990:153-184.
57. Hadigan CM, Walsh BT, Buttinger C, Hollander E. Behavioral and neuroendocrine responses to metaCPP in anorexia nervosa. Biol Psychiatry. 1995;37: 504-511.
58. Schweiger U, Pirke KM, Laessle RG, Fichter MM. Gonadotropin secretion in bulimia nervosa. J Clin Endocrinol Metab. 1992;74:1122-1127.